Sign in

CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
011441223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$64,039
in 7 filings, $7K under 10b5-1 plans

Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-06-28 Keen Nicholas Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +177,404 177,404
2019-05-29 Cambridge Innovation Capital (Jersey) Ltd 10% owner Purchase +314,286 $14.00 $4.4M 1,751,437
2019-05-28 TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% owner Conversion +1,454,411 1,454,411
2019-05-28 TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% owner Option exercise +139,264 1,593,675
2019-05-28 TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% owner Purchase +364,286 $14.00 $5.1M 1,957,961
2019-05-28 TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% owner Option exercise · Series B2 Preferred Shares Warrants −139,264 0
2019-05-28 Cambridge Innovation Capital (Jersey) Ltd 10% owner Conversion +1,081,823 1,081,823
2019-05-28 Cambridge Innovation Capital (Jersey) Ltd 10% owner Option exercise +125,587 1,207,410
2019-05-28 Cambridge Innovation Capital (Jersey) Ltd 10% owner Conversion +229,741 1,437,151
2019-05-28 Cambridge Innovation Capital (Jersey) Ltd 10% owner Conversion · Series B1 Preferred Shares −1,081,823 0
2019-05-28 Cambridge Innovation Capital (Jersey) Ltd 10% owner Option exercise · Series B1 Preferred Shares Warrants −125,587 0
2019-05-28 Cambridge Innovation Capital (Jersey) Ltd 10% owner Conversion · Series B2 Preferred Shares −229,741 0
2019-05-28 NG CAROLYN Director Conversion +1,272,733 1,081,823
2019-05-28 NG CAROLYN Director Option exercise +141,668 1,207,410
2019-05-28 NG CAROLYN Director Conversion +206,767 1,427,151
2019-05-28 NG CAROLYN Director Conversion · Series B1 Preferred Shares −1,272,733 0
2019-05-28 NG CAROLYN Director Option exercise · Series B1 Preferred Shares Warrants −141,668 0
2019-05-28 NG CAROLYN Director Conversion · Series B2 Preferred Shares −206,767 0
2019-05-28 Vertex Global Healthcare Fund I Pte Ltd. 10% owner Conversion +1,272,733 1,272,733
2019-05-28 Vertex Global Healthcare Fund I Pte Ltd. 10% owner Option exercise +141,668 1,414,401

Page 30 of 34 · 664 trades